Statistics
Publications
21
Citations
5.2K
H-Index
17
Active since
2001
Stefanie S. Schalm is an author at Blueprint Medicines (United States) specializing in medicine, oncology, and life sciences.
Publications per year
2001–2024
21
21
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
The landscape of kinase fusions in cancer
Nicolas Stransky, Ethan Cerami, Stefanie S. Schalm et al. · Nature Communications · 2014 · 969 citations · Full text
Medicine, Cancer Biology, Oncology +17
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations
Medicine, Cancer Biology, Oncology +10
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki, Christiane B. Knobbe‐Thomsen, Joshua Munger et al. · Nature · 2012 · 507 citations · Full text
Life Sciences, Genetics, Hematology +13
1–5 of 21